Joud H Haidar
Overview
Explore the profile of Joud H Haidar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haidar J, Shamseddine A, Salem Z, Mrad Y, Nasr M, Zaatari G, et al.
Eur J Haematol
. 2003 Apr;
70(5):330-2.
PMID: 12694172
The response rate at relapse to rituximab in prior responders B-cell non-Hodgkin's lymphoma (NHL) patients is below 50%. Loss of CD20 expression after rituximab therapy may explain this secondary resistance....
2.
Haidar J, Bazarbachi A, Nasr M, El-Sabban M, Daher R
Eur J Haematol
. 2003 Mar;
70(4):249-50.
PMID: 12656751
The morphological presentation of malignant plasma cells in multiple myeloma (MM) varies from mature to anaplastic plasma cells with only one reported case of signet ring variant. We describe here...
3.
Haidar J, Bazarbachi A, Mahfouz R, Abi Haidar H, Jaafar H, Daher R
J Hematother Stem Cell Res
. 2002 Aug;
11(3):533-8.
PMID: 12183838
Flt3 ligand (FL) is a good indicator of bone marrow (BM) cellularity, having a reciprocal relationship with white blood cell (WBC) count in aplastic anemia and chemotherapy-induced neutropenia. In this...
4.
Daher R, Haidar J, Al-Amin H
Clin Chem
. 2001 Dec;
48(1):203-4.
PMID: 11751562
No abstract available.